Intervention

Doxorubicin Hydrochloride

ClinicalTrials.gov intervention label

Clinical trials22
Recruiting1
Common conditions25
Lead sponsors shown10

Clinical trials

22 shown
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic LymphomaNCT04139304 · 2021-05-24
RECRUITING
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")NCT07649304 · 2026-10-09
NOT_YET_RECRUITING
Chemokine Modulation Therapy and Standard Chemotherapy Before Surgery for the Treatment of Early Stage Triple Negative Breast CancerNCT04081389 · 2019-12-06
COMPLETED
Breast Cancer Treatment Based on Organ-like CultureNCT03925233 · 2019-01-02
UNKNOWN
Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell LymphomasNCT03220022 · 2018-03-16
ACTIVE_NOT_RECRUITING
Pembrolizumab and Doxorubicin Hydrochloride or Anti-Estrogen Therapy in Treating Patients With Triple-Negative or Hormone Receptor-Positive Metastatic Breast CancerNCT02648477 · 2016-03-28
COMPLETED
Gene Therapy and Combination Chemotherapy in Treating Patients With AIDS-Related Non-Hodgkin LymphomaNCT02337985 · 2015-11-20
ACTIVE_NOT_RECRUITING
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast CancerNCT02488967 · 2015-07-26
ACTIVE_NOT_RECRUITING
Combination Chemotherapy With or Without Ganitumab in Treating Patients With Newly Diagnosed Metastatic Ewing SarcomaNCT02306161 · 2014-12-12
ACTIVE_NOT_RECRUITING
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast CancerNCT01897441 · 2013-06-01
TERMINATED
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin LymphomaNCT01771107 · 2013-03-08
COMPLETED
Paclitaxel & Cyclophosphamide With or Without Trastuzumab Before Surgery in Treating Previously Untreated Breast CancerNCT01750073 · 2012-12-07
COMPLETED
PTX-200, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast CancerNCT01697293 · 2012-01-01
TERMINATED
Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast CancerNCT01275677 · 2011-02-08
COMPLETED
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasNCT01193842 · 2010-10-06
COMPLETED
Paclitaxel With or Without Carboplatin and/or Bevacizumab Followed by Doxorubicin and Cyclophosphamide in Treating Patients With Breast Cancer That Can Be Removed by SurgeryNCT00861705 · 2009-07-21
COMPLETED
Topotecan Hydrochloride and Doxorubicin Hydrochloride in Treating Relapsed or Refractory Small Cell Lung CancerNCT00856037 · 2009-02-02
COMPLETED
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast CancerNCT00433511 · 2007-11-02
ACTIVE_NOT_RECRUITING
Doxorubicin and Strontium-89 With or Without Celecoxib in Treating Patients With Progressive Androgen-Independent Prostate Cancer and Bone MetastasesNCT00080782 · 2002-02-01
TERMINATED
Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast CancerNCT00005970 · 2000-05-19
COMPLETED
Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate CancerNCT00003084 · 1997-12-01
COMPLETED
High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Breast CancerNCT00002837 · 1995-09-01
COMPLETED

Common conditions

HER2/Neu Negative5Triple-Negative Breast Carcinoma5Breast Adenocarcinoma4Estrogen Receptor Negative4Progesterone Receptor Negative4Stage IIB Breast Cancer4Stage IIIA Breast Cancer4Stage IIIC Breast Cancer4Ann Arbor Stage II Diffuse Large B-Cell Lymphoma3Ann Arbor Stage III Diffuse Large B-Cell Lymphoma3Ann Arbor Stage IV Diffuse Large B-Cell Lymphoma3Estrogen Receptor Positive3HIV Infection3Plasmablastic Lymphoma3Progesterone Receptor Positive3Stage IIA Breast Cancer3Stage IIA Breast Cancer AJCC v6 and v73Stage IIB Breast Cancer AJCC v6 and v73Stage IIIA Breast Cancer AJCC v73Stage IIIB Breast Cancer3Stage IV Breast Cancer3AIDS-Related Diffuse Large B-cell Lymphoma2AIDS-Related Plasmablastic Lymphoma2AIDS-Related Primary Effusion Lymphoma2Ann Arbor Stage I Diffuse Large B-Cell Lymphoma2

Trial status mix

COMPLETED11
ACTIVE_NOT_RECRUITING5
TERMINATED3
NOT_YET_RECRUITING1
RECRUITING1
UNKNOWN1

Phase mix

PHASE19
PHASE29
PHASE35
EARLY_PHASE11
NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.